Hosted on MSN12mon
AriBio licenses Alzheimer’s pill in China for up to $770m
a PDE5 inhibitor, is currently being evaluated in the POLARIS-AD Phase III trial (NCT05531526). The randomised trial compares AriBio’s drug against placebo to slow the progression of Alzheimer ...
Knowridge Science Report8d
This drug could treat obesity without diet changes
Obesity is a major global health issue, increasing the risk of heart disease, diabetes, and high blood pressure. Despite many ...
Nature5y
Mirodenafil: a new PDE5 inhibitor for the treatment of erectile dysfunction
A new study reports that mirodenafil, a newly developed oral phosphodiesterase type 5 (PDE5) inhibitor, is an efficacious and safe treatment for erectile dysfunction (ED). Many men with ED ...
Medscape11y
Phosphodiesterase Inhibitors in Clinical Urology
The use of isoenzyme-selective phosphodiesterase (PDE) inhibitors is considered a great opportunity to treat various diseases of the human urogenital tract. PDE inhibitors, in particular the PDE5 ...